Entegris (ENTG) has an average rating of overweight and mean price target of $167.70, according to analysts polled by FactSet.
What else is happening in Research?
Research
TELUS Downgraded to Underperform at BofA Securities
TELUS (T.TO) was downgraded to Underperform from Buy at Bank of America Securities on Tuesday.The price objective was cut to C$13 from C$22 on a "materially lower" free cash flow outlook for 2028, the firm said in a note."Our bull thesis of strong FCF growth and execution on monetizations has not played out, resulting in our changed view," BofA Securities said.Price: $13.09, Change: $-0.29, Percent Change: -2.17%
$T$T.TO
Research
Oppenheimer Upgrades Inspire Medical Systems to Outperform From Perform, $85 Price Target
Inspire Medical Systems (INSP) has an average rating of hold and mean price target of $57.21, according to analysts polled by FactSet.
$INSP
Research
Needham Initiates Vishay Intertechnology at Buy With $45 Price Target
Vishay Intertechnology (VSH) has an average rating of overweight and mean price target of $38.25, according to analysts polled by FactSet.
$VSH